Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Number of atenolol prescriptions in the U.S. 2004-2016

Number of atenolol prescriptions in the U.S. from 2004 to 2016 (in millions)

by Matej Mikulic, last edited Nov 14, 2018
Number of atenolol prescriptions in the U.S. 2004-2016 This statistic shows the total annual number of atenolol prescriptions in the U.S. from 2004 to 2016, in millions. In 2004, atenolol was prescribed over 46 million times. As of 2016, there were almost 27 million atenolol prescriptions made in the U.S. Atenolol is used primarily for the treatment of cardiovascular diseases.
Show more

Number of atenolol prescriptions in the U.S. from 2004 to 2016 (in millions)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "U.S. pharmaceutical industry"
  • Contribution to global pharma
The most important statistics
  • Overview
  • Companies
  • Research and development
  • Generics
  • Outlook
  • The consumer's view
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.